Effimune SA (extinct)

Effimune SA (extinct)

Effimune SA (extinct)

Overview
Date Founded

2007

Headquarters

1, rue Gaston Veil,Nantes, Pays-de-la-Loire (Loire Valley) 44000

Type of Company

Private

Industries

Biotechnology

Company Description

Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France.

Paths to Effimune SA
Potential Connections via
Relationship Science
You
Effimune SA
Recent Transactions
Details Hidden

Orphan Synergy Europe-Pharma SA purchases Effimune SA resulting in a new company OSE Immunotherapeutics SA

Transaction Advisors
Legal Advisor

Advised onOrphan Synergy Europe-Pharma SA purchases Effimune SA resulting in a new company OSE Immunotherapeutics SA

Investors
Details Hidden

Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland.

Details Hidden
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Effimune SA. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Effimune SA's profile does not indicate a business or promotional relationship of any kind between RelSci and Effimune SA.